PHASE 2 STUDY OF PEVONEDISTAT + AZACITIDINE VERSUS AZACITIDINE IN PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES/CHRONIC MYELOMONOCYTIC LEUKEMIA OR LOW-BLAST ACUTE MYELOGENOUS LEUKEMIA (NCT02610777)
Adès, L., Watts, J., Radinoff, A., Sangerman, M.A., Cerrano, M., Lopez, P.F., Zeidner, J., Campelo, M.D., Graux, C., Liesveld, J., Selleslag, D., Tzvetkov, N., Fram, R.J., Zhao, D., Bell, J., Friedlander, S., Faller, D.V., Sekeres, M.A.
Published in Hematology, Transfusion and Cell Therapy (01.11.2020)
Published in Hematology, Transfusion and Cell Therapy (01.11.2020)
Get full text
Journal Article
Breakfast jeopardize thyroid function assays: an evaluation on behalf of COLABIOCLI WG-PRE-LATAM
Lima-Oliveira, G., Bajaña, W., Aranda, E., Arredondo, M.E., Brennan-Bourdon, L.M., Campelo, M.D., Espinoza, E., Flores, S., Ochoa, P., Vega, V., Varela, B.
Published in Clinica chimica acta (01.06.2019)
Published in Clinica chimica acta (01.06.2019)
Get full text
Journal Article